Aging, neuroinflammation, and behavior

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 379-391

  Johnson, Rodney W ^a   Godbout, Jonathan P ^b,c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Institute for Behavioral Medicine Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882557196     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50022-8     Document Type: Chapter

References (130)

1. Armstrong G.L., Conn L.A., Pinner R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA 1999, 281:61-66.
2. Atkins E. Pathogenesis of fever. Physiol. Rev. 1960, 40:580-646.
3. Ban E., Haour F., Lenstra R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 1992, 4:48-54.
4. Banks W.A., Kastin A.J. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci. 1991, 48. PL117-121.
5. Banks W.A., Kastin A.J., Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 1995, 2:241-248.
6. Banks W.A., Kastin A.J., Gutierrez E.G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci. Lett 1994, 179:53-56.
7. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 1991, 259:988-996.
8. Barrientos R.M., Higgins E.A., Biedenkapp J.C., Sprunger D.B., Wright-Hardesty K.J., Watkins L.R., Rudy J.W., Maier S.F. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol. Aging. 2006.
9. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 1998, 78:547-581.
10. Berg B.M., Godbout J.P., Chen J., Kelley K.W., Johnson R.W. Alpha-tocopherol and selenium facilitate recovery from lipopolysaccharide-induced sickness in aged mice. J. Nutr. 2005, 135:1157-1163.
11. Berg B.M., Godbout J.P., Kelley K.W., Johnson R.W. Alpha-tocopherol attenuates lipopolysaccharide-induced sickness behavior in mice. Brain Behav. Immun. 2004, 18:149-157.
12. Besedovsky H.O., del Rey A., Sorkin E. Lymphokinecontaining supernatants from con A-stimulated cells increase corticosterone blood levels. J. Immunol. 1981, 126:385-387.
13. Blalock E.M., Chen K.C., Sharrow K., Herman J.P., Porter N.M., Foster T.C., Landfield P.W. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 2003, 23:3807-3819.
14. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P., Grubeck-Loebenstein B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 2004, 3:169-176.
15. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport 1996, 7:2823-2827.
16. Bluthe R.M., Michaud B., Kelley K.W., Dantzer R. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport 1996, 7:1485-1488.
17. Brugg B., Dubreuil Y.L., Huber G., Wollman E.E., Delhaye-Bouchaud N., Mariani J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. USA 1995, 92:3032-3035.
18. Calhoun M.E., Kurth D., Phinney A.L., Long J.M., Hengemihle J., Mouton P.R., Ingram D.K., Jucker M. Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice. Neurobiol. Aging 1998, 19:599-606.
19. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 1993, 90:10061-10065.
20. Castle S.C. Clinical relevance of age-related immune dysfunction. Clin. Infect Dis. 2000, 31:578-585.
21. Chiovenda P., Vincentelli G.M., Alegiani F. Cognitive impairment in elderly ED patients: need for multidimensional assessment for better management after discharge. Am. J. Emerg. Med. 2002, 20:332-335.
22. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in preclinical murine prion disease. Neuroscience 2002, 112:7-11.
23. Cunningham C., Deacon R., Wells H., Boche D., Waters S., Diniz C.P., Scott H., Rawlins J.N., Perry V.H. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur. J. Neurosci. 2003, 17:2147-2155.
24. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 2001, 933:222-234.
25. Dantzer R. Innate immunity at the forefront of psychoneuroimmunology. Brain Behav. Immun. 2004, 18:1-6.
26. Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.Z., Ryu S.Y. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol. 1993, 150:5219-5230.
27. de Brabander J.M., Kramers R.J., Uylings H.B. Layerspecific dendritic regression of pyramidal cells with aging in the human prefrontal cortex. Eur. J. Neurosci. 1998, 10:1261-1269.
28. Dunn N., Mullee M., Perry V.H., Holmes C. Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis. Assoc. Disord. 2005, 19:91-94.
29. Eikelenboom P., Hoogendijk W.J., Jonker C., van Tilburg W. Immunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease. J. Psychiatr. Res. 2002, 36:269-280.
30. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA 2003, 100:13632-13637.
31. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 2000, 51:245-270.
32. Finch C.E. Neurons, glia, and plasticity in normal brain aging. Neurobiol. Aging 2003, 24(Suppl 1):S123-S127. discussion S131.
33. Finch C.E., Crimmins E.M. Inflammatory exposure and historical changes in human life-spans. Science 2004, 305:1736-1739.
34. Finck B.N., Johnson R.W. Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1beta in the rat. Brain Res. 1997, 761:333-337.
35. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-kappa B activation. Free Radic. Biol. Med. 1997, 22:1115-1126.
36. Frank M.G., Barrientos R.M., Biedenkapp J.C., Rudy J.W., Watkins L.R., Maier S.F. mRNA up-regulation of MHC II and pivotal pro-Inflammatory genes in normal brain aging. Neurobiol. Aging. 2006.
37. Ginaldi L., De Martinis M., Monti D., Franceschi C. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol. 2005, 26:79-84.
38. Ginaldi L., Loreto M.F., Corsi M.P., Modesti M., De Martinis M. Immunosenescence and infectious diseases. Microbes Infect. 2001, 3:851-857.
39. Giulian D. Microglia and the immune pathology of Alzheimer disease. Am. J. Hum. Genet. 1999, 65:13-18.
40. Godbout J.P., Berg B.M., Kelley K.W., Johnson R.W. Alpha-tocopherol reduces lipopolysaccharide-induced peroxide radical formation and interleukin-6 secretion in primary murine microglia and in brain. J. Neuroimmunol. 2004, 149:101-109.
41. Godbout J.P., Berg B.M., Krzyszton C., Johnson R.W. Alpha-tocopherol attenuates NF B activation and pro-Inflammatory cytokine production in brain and improves recovery from lipopolysaccharide-induced sickness b. J. Neuroimmunol. 2005, 169:97-105.
42. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., Johnson R.W. Exaggerated neuroinflammation and sickness in aged mice following activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1331.
43. Godbout J.P., Johnson R.W. Interleukin-6 in the aging brain. J. Neuroimmunol. 2004, 147:141-144.
44. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., Watkins L.R. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. J. Neurosci. 1999, 19:2799-2806.
45. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., Watkins L.R. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 1997, 43:357-364.
46. Gorczynski R.M., Cinader B., Ramakrishna V., Terzioglu E., Waelli T., Westphal O. An antibody specific for interleukin-6 reverses age-associated changes in spontaneous and induced cytokine production in mice. Immunology 1997, 92:20-25.
47. Guo Z., Ersoz A., Butterfield D.A., Mattson M.P. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J. Neurochem. 2000, 75:314-320.
48. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J. Neuroimmunol. 1993, 47:169-176.
49. Heyser C.J., Masliah E., Samimi A., Campbell I.L., Gold L.H. Progressive decline in avoidance learning paralleled by Inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. USA 1997, 94:1500-1505.
50. Holmes C., El-Okl M., Williams A.L., Cunningham C., Wilcockson D., Perry V.H. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:788-789.
51. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4) -deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
52. Jackson J.C., Gordon S.M., Hart R.P., Hopkins R.O., Ely E.W. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol. Rev. 2004, 14:87-98.
53. Jacobs B., Driscoll L., Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J. Comp. Neurol. 1997, 386:661-680.
54. Janssens J.P., Krause K.H. Pneumonia in the very old. Lancet Infect. Dis. 2004, 4:112-124.
55. Johnson R.W. The concept of sickness behavior: a brief chronological account of four key discoveries. Vet. Immunol. Immunopathol. 2002, 87:443-450.
56. Johnson R.W., Gheusi G., Segreti S., Dantzer R., Kelley K.W. C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Res. 1997, 752:219-226.
57. Johnston M., Wakeling A., Graham N., Stokes F. Cognitive impairment, emotional disorder and length of stay of elderly patients in a district general hospital. Br. J. Med. Psychol. 1987, 60:133-139. Pt 2.
58. Joseph J.A., Shukitt-Hale B., Denisova N.A., Prior R.L., Cao G., Martin A., Taglialatela G., Bickford P.C. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral def. J. Neurosci. 1998, 18:8047-8055.
59. Kiecolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annu. Rev. Psychol. 2002, 53:83-107.
60. Kirkwood T.B., Feder M., Finch C.E., Franceschi C., Globerson A., Klingenberg C.P., LaMarco K., Omholt S., Westendorp R.G. What accounts for the wide variation in life span of genetically identical organisms reared in a constant environment?. Mech. Aging Dev. 2005, 126:439-443.
61. Konsman J.P., Kelley K., Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience 1999, 89:535-548.
62. Korhonen P., Helenius M., Salminen A. Age-related changes in the regulation of transcription factor NF-kappa B in rat brain. Neurosci. Lett. 1997, 225:61-64.
63. Krueger J.M., Walter J., Dinarello C.A., Wolff S.M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am. J. Physiol. 1984, 246:R994-R999.
64. Laflamme N., Rivest S. Toll-like receptor 4, the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 2001, 15:155-163.
65. Laflamme N., Soucy G., Rivest S. Circulating cell wall components derived from gram-negative, not gram-positive, bacteria cause a profound induction of the gene-encoding tolllike receptor 2 i. J. Neurochem. 2001, 79:648-657.
66. Laye S., Bluthe R.M., Kent S., Combe C., Medina C., Parnet P., Kelley K., Dantzer R. Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am. J. Physiol. 1995, 268:R1327-R1331.
67. Laye S., Parnet P., Goujon E., Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 1994, 27:157-162.
68. Lee C.K., Weindruch R., Prolla T.A. Gene-expression profile of the aging brain in mice. Nat. Genet. 2000, 25:294-297.
69. Li N., Karin M. Is NF-kappaB the sensor of oxidative stress?. FASEB J. 1999, 13:1137-1143.
70. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 1990, 10:2327-2334.
71. Mattson M.P., Duan W., Guo Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 2003, 84:417-431.
72. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
73. Moser M.B., Trommald M., Andersen P. An increase in dendritic spine density on hippocampal CA1 pyramidal cells following spatial learning in adult rats suggests the formation of new synapses. Proc. Natl. Acad. Sci. USA 1994, 91:12673-12675.
74. Mouton P.R., Long J.M., Lei D.L., Howard V., Jucker M., Calhoun M.E., Ingram D.K. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 2002, 956:30-35.
75. Munch G., Gasic-Milenkovic J., Dukic-Stefanovic S., Kuhla B., Heinrich K., Riederer P., Huttunen H.J., Founds H., Sajithlal G. Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp. Brain Res. 2003, 150:1-8.
76. Murray C.A., Lynch M.A. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyrus. J. Biol.Chem. 1998, 273:12161-12168.
77. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., Barde Y.A. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 2002, 22:854-862.
78. Nguyen M.D., D'Aigle T., Gowing G., Julien J.P., Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2004, 24:1340-1349.
79. O'Donnell E., Lynch M.A. Dietary antioxidant supplementation reverses age-related neuronal changes. Neurobiol. Aging 1998, 19:461-467.
80. Ortega R.M., Requejo A.M., Lopez-Sobaler A.M., Andres P., Navia B., Perea J.M., Robles F. Cognitive function in elderly people is influenced by vitamin E status. J. Nutr. 2002, 132:2065-2068.
81. Perry V.H. The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav. Immun. 2004, 18:407-413.
82. Perry V.H., Matyszak M.K., Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia 1993, 7:60-67.
83. Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003, 4:103-112.
84. Peters A. Structural changes in the normally aging cerebral cortex of primates. Prog. Brain Res. 2002, 136:455-465.
85. Pinner R.W., Teutsch S.M., Simonsen L., Klug L.A., Graber J.M., Clarke M.J., Berkelman R.L. Trends in infectious diseases mortality in the United States. JAMA 1996, 275:189-193.
86. Plowden J., Renshaw-Hoelscher M., Engleman C., Katz J., Sambhara S. Innate immunity in aging: impact on macrophage function. Aging Cell 2004, 3:161-167.
87. Porter N.M., Landfield P.W. Stress hormones and brain aging: adding injury to insult?. Nat. Neurosci. 1998, 1:3-4.
88. Poynter M.E., Daynes R.A. Age-associated alterations in splenic iNOS regulation: influence of constitutively expressed IFN-gamma and correction following supplementation with PPARalph activators or vitamin E. Cell. Immunol. 1999, 195:127-136.
89. Prechel M.M., Halbur L., Devata S., Vaidya A.M., Young M.R. Increased interleukin-6 production by cerebral cortical tissue of adult versus young mice. Mech. Aging Dev. 1996, 92:185-194.
90. Rapp P.R., Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci. USA 1996, 93:9926-9930.
91. Rasmussen T., Schliemann T., Sorensen J.C., Zimmer J., West M.J. Memory impaired aged rats: no loss of principal hippocampal and subicular neurons. Neurobiol. Aging 1996, 17:143-147.
92. Reyes T.M., Fabry Z., Coe C.L. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res. 1999, 851:215-220.
93. Richwine A.F., Godbout J.P., Chen J., Berg B.M., Escobar J., Millard D.K., Johnson R.W. An antioxidant-rich diet reduced brain interleukin-6 production and improved psychomotor performance in aged mice. Brain Behav. Immun. 2005, 19:512-520.
94. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17:13-19.
95. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 1988, 9:339-349.
96. Sa M.J., Madeira M.D., Ruela C., Volk B., Mota-Miranda A., Lecour H., Goncalves V., Paula-Barbosa M.M. AIDS does not alter the total number of neurons in the hippocampal formation but induces cell atrophy: a stereological study. Acta Neuropathol. (Berl) 2000, 99:643-653.
97. Sa M.J., Madeira M.D., Ruela C., Volk B., Mota-Miranda A., Paula-Barbosa M.M. Dendritic changes in the hippocampal formation of AIDS patients: a quantitative Golgi study. Acta Neuropathol. (Berl) 2004, 107:97-110.
98. Schapira A.H., Olanow C.W. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 2004, 291:358-364.
99. Scheibel M.E., Lindsay R.D., Tomiyasu U., Scheibel A.B. Progressive dendritic changes in aging human cortex. Exp. Neurol. 1975, 47:392-403.
100. Segreti J., Gheusi G., Dantzer R., Kelley K.W., Johnson R.W. Defect in interleukin-1beta secretion prevents sickness behavior in C3H/HeJ mice. Physiol. Behav. 1997, 61:873-878.
101. Sheffield L.G., Berman N.E. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol. Aging 1998, 19:47-55.
102. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 1:1313-1315.
103. Silva-Gomez A.B., Rojas D., Juarez I., Flores G. Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats. Brain Res. 2003, 983:128-136.
104. Sly L.M., Krzesicki R.F., Brashler J.R., Buhl A.E., McKinley D.D., Carter D.B., Chin J.E. Endogenous brain cytokine mRNA and Inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res. Bull. 2001, 56:581-588.
105. Spencer N.F., Poynter M.E., Im S.Y., Daynes R.A. Constitutive activation of NF-kappa B in an animal model of aging. Int. Immunol. 1997, 9:1581-1588.
106. Streit W.J. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 2004, 77:1-8.
107. Streit W.J., Sammons N.W., Kuhns A.J., Sparks D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45:208-212.
108. Streit W.J., Sparks D.L. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J. Mol. Med. 1997, 75:130-138.
109. Terai K., Matsuo A., McGeer P.L. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res. 1996, 735:159-168.
110. Tha K.K., Okuma Y., Miyazaki H., Murayama T., Uehara T., Hatakeyama R., Hayashi Y., Nomura Y. Changes in expressions of proInflammatory cytokines IL-1beta, TNFalpha and IL-6 in the brain of senescence accelerated mouse (SAM)P8. Brain Res. 2000, 885:25-31.
111. Toliver-Kinsky T., Papaconstantinou J., Perez-Polo J.R. Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity. J. Neurosci. Res. 1997, 48:580-587.
112. van Dam A.M., Bauer J., Tilders F.J., Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 1995, 65:815-826.
113. van Dam A.M., Brouns M., Louisse S., Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific sym of sickness?. Brain Res. 1992, 588:291-296.
114. Vereker E., O'Donnell E., Lynch M.A. The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 2000, 20:6811-6819.
115. Verkhratsky A., Mattson M.P., Toescu E.C. Aging in the mind. Trends Neurosci. 2004, 27:577-578.
116. Weaver J.D., Huang M.H., Albert M., Harris T., Rowe J.W., Seeman T.E. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002, 59:371-378.
117. Wei J., Xu H., Davies J.L., Hemmings G.P. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 1992, 51:1953-1956.
118. West M.J. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging 1993, 14:287-293.
119. Whalley L.J., Deary I.J., Appleton C.L., Starr J.M. Cognitive reserve and the neurobiology of cognitive aging. Aging Res. Rev. 2004, 3:369-382.
120. Wiley C.A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann. Neurol. 1991, 29:651-657.
121. Willard L.B., Hauss-Wegrzyniak B., Wenk G.L. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience 1999, 88:193-200.
122. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition-the case for a head-to-toe Inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50:2041-2056.
123. Wofford J.L., Loehr L.R., Schwartz E. Acute cognitive impairment in elderly ED patients: etiologies and outcomes. Am. J. Emerg. Med. 1996, 14:649-653.
124. Wofford J.L., Schwartz E., Timerding B.L., Folmar S., Ellis S.D., Messick C.H. Emergency dePARTment utilization by the elderly: analysis of the National Hospital Ambulatory Medical Care Survey. Acad. Emerg. Med. 1996, 3:694-699.
125. Xie Z., Morgan T.E., Rozovsky I., Finch C.E. Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity. Exp. Neurol. 2003, 182:135-141.
126. Yao J.H., Ye S.M., Burgess W., Zachary J.F., Kelley K.W., Johnson R.W. Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am. J. Physiol. 1999, 277:R1435-R1443.
127. Ye S.M., Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 1999, 93:139-148.
128. Ye S.M., Johnson R.W. An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 2001, 9:183-192.
129. Ye S.M., Johnson R.W. Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB. J. Neuroimmunol. 2001, 117:87-96.
130. Zandi P.P., Anthony J.C., Khachaturian A.S., Stone S.V., Gustafson D., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Breitner J.C. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch. Neurol. 2004, 61:82-88.